The heparin-binding or fibroblast growth factors (HBGFs) modulate cell growth and migration, angiogenesis, wound repair, neurite extension, and mesoderm induction. Relatively little is known regarding the precise mechanism of action of these growth factors or the structural basis for their action. A
Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide
β Scribed by Kenji Ogura; Koji Nagata; Hideki Hatanaka; Hiroko Habuchi; Koji Kimata; Shin-ichi Tate; Mark W. Ravera; Michael Jaye; J. Schlessinger; Fuyuhiko Inagaki
- Book ID
- 110262239
- Publisher
- Springer Netherlands
- Year
- 1999
- Tongue
- English
- Weight
- 319 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0925-2738
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Substance P (SP), fibroblast growth factor (FCF), and epidermal growth factor (EGF) are mitogens for fibroblasts. EGF acts as a progression factor, whereas FGF and SP have competence factor activity. The ability of eicosanoids to regulate proliferation of fibroblasts and the increased production of
Fibroblast growth factors (FGF) are a family of heparin-binding angiogenic polypeptide mitogens. In the presence of heparin, recombinant human basic fibroblast growth factor (bFGF) is fully protected from tryptic digestion and partially protected from chymotryptic digestion. Complete protection of b